Unmasking Complex Chromosomal Rearrangement Impacting CHD2 by Genome Sequencing and Optical Genome Mapping in Developmental and Epileptic Encephalopathy—DEE94
Neuropediatrics · 01.06.2026 · 57 (03) · 226-231
DOI: 10.1055/a-2856-1470 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropediatrics, erschienen am 01.06.2026. Verfasst von Robin Wijngaard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Developmental Disabilities, Lennox Gastaut Syndrome.
Abstract (Originalsprache)
AbstractDevelopmental and epileptic encephalopathy (DEE) is extremely heterogeneous and only 30 to 50% of affected individuals receive a diagnosis upon routine genetic diagnostics. We show that genome sequencing, complemented by optical genome mapping (OGM), resolved an exome-negative case.We performed trio short-read genome sequencing, karyotyping, OGM, and quantitative real-time PCR.In a boy with DEE (severe global developmental delay/intellectual disability, early-onset, multiple and concurrent seizures, EEG suggestive of Lennox-Gastaut syndrome, dystonic tetraplegia), routine diagnostic testing (karyotyping, array-CGH, and exome sequencing) failed to yield a diagnosis. Genome sequencing detected a de novo translocation that OGM validated and expanded to a complex chromosomal rearrangement (CCR) involving seven breakpoints in chromosomes 5, 9, 12, and 15. The breakpoint on chromosome 15 affected the 5′UTR promotor region of CHD2. Quantitative real-time PCR on RNA from proband-derived lymphoblast cells showed a 40% reduction of CHD2 expression confirming the pathogenicity of the variant.Our case highlights that CCR can underly CHD2-related DEE94 and likely underlie other (genetically unsolved) cases. There is not one technique that can detect all genetic variants. We emphasize the advantage of combining genome sequencing with OGM as a complementary second step in unresolved cases to improve the detection and structural characterization of genetic variation, including CCRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Pediatrics, Hippokratio General Hospital, Aristotle University, Thessaloniki, Greece.
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
- Translational Metabolic Laboratory, Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
- University Children's Hospital, Paracelsus Medical University, Salzburg, Austria.
ORCID-Profile: Machteld M Oud
Zitieren
APA
Wijngaard, R., Dragoumi, P., Neveling, K., van Beek, R., van de Zande, G., Wevers, R. A., Zafeiriou, D., Oud, M. M., & Wortmann, S. B. (2026). Unmasking Complex Chromosomal Rearrangement Impacting CHD2 by Genome Sequencing and Optical Genome Mapping in Developmental and Epileptic Encephalopathy—DEE94. Neuropediatrics, 57(03), 226-231. https://doi.org/10.1055/a-2856-1470
Vancouver
Wijngaard R, Dragoumi P, Neveling K, van Beek R, van de Zande G, Wevers RA, et al. Unmasking Complex Chromosomal Rearrangement Impacting CHD2 by Genome Sequencing and Optical Genome Mapping in Developmental and Epileptic Encephalopathy—DEE94. Neuropediatrics. 2026;57(03):226-231. doi:10.1055/a-2856-1470
BibTeX
@article{Wijngaard2026,
author = {Wijngaard, Robin and Dragoumi, Pinelopi and Neveling, Kornelia and van Beek, Ronald and van de Zande, Guillaume and Wevers, Ron A and Zafeiriou, Dimitrios and Oud, Machteld M and Wortmann, Saskia B},
title = {Unmasking Complex Chromosomal Rearrangement Impacting CHD2 by Genome Sequencing and Optical Genome Mapping in Developmental and Epileptic Encephalopathy—DEE94},
journal = {Neuropediatrics},
year = {2026},
volume = {57},
number = {03},
pages = {226--231},
doi = {10.1055/a-2856-1470}
}
EUVIMED